M Arns1, J-M Batail2, S Bioulac3, M Congedo4, C Daudet5, D Drapier2, T Fovet6, R Jardri6, M Le-Van-Quyen7, F Lotte8, D Mehler9, J-A Micoulaud-Franchi10, D Purper-Ouakil11, F Vialatte12. 1. Research Institute Brainclinics, Bijleveldsingel 34, 6524 AD Nijmegen, Netherlands; Department of Experimental Psychology, Utrecht University, Domplein 29, 3512 JE Utrecht, Netherlands. 2. Academic Psychiatry Department, centre hospitalier Guillaume-Régnier, 108, avenue du Général-Leclerc, 35000 Rennes, France; EA 4712 Behavior and Basal Ganglia, Rennes 1 University, CHU de Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France. 3. Université de Bordeaux, SANPSY, USR 3413, 33000 Bordeaux, France; CNRS, SANPSY, USR 3413, 33000 Bordeaux, France. 4. GIPSA-lab, CNRS and Grenoble Alpes University, 38400 Grenoble, France. 5. Université de Bordeaux, 33000 Bordeaux, France. 6. Université Lille, CNRS UMR9193, SCALab, PsyCHIC team & CHU Lille, Fontan hospital, CURE platform, 59000 Lille, France. 7. Institut du cerveau et de la moelle epinière, UMRS 1127, CNRS UMR 7225, hôpital de la Pitié-Salpêtrière, 75013 Paris, France; Université Pierre-et-Marie-Curie, Paris 6, 75005 Paris, France. 8. Inria Bordeaux Sud-Ouest, Project-Team Potioc/LaBRI, 33405 Talence, France. 9. Cardiff University Brain Imaging Centre (CUBRIC), School of Psychology, Cardiff University, United Kingdom; Department of Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany. 10. Université de Bordeaux, SANPSY, USR 3413, 33000 Bordeaux, France; CNRS, SANPSY, USR 3413, 33000 Bordeaux, France. Electronic address: jarthur.micoulaud@gmail.com. 11. CHU de Montpellier Saint-Éloi, médecine psychologique pour enfants et adolescents (MPEA1), 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France. 12. Laboratoire plasticité du cerveau, UMR 8249, ESPCI Paris Tech, PSL Research University, 10, rue Vauquelin, 75005 Paris, France.
Abstract
OBJECTIVES: Neurofeedback is a technique that aims to teach a subject to regulate a brain parameter measured by a technical interface to modulate his/her related brain and cognitive activities. However, the use of neurofeedback as a therapeutic tool for psychiatric disorders remains controversial. The aim of this review is to summarize and to comment the level of evidence of electroencephalogram (EEG) neurofeedback and real-time functional magnetic resonance imaging (fMRI) neurofeedback for therapeutic application in psychiatry. METHOD: Literature on neurofeedback and mental disorders but also on brain computer interfaces (BCI) used in the field of neurocognitive science has been considered by the group of expert of the Neurofeedback evaluation & training (NExT) section of the French Association of biological psychiatry and neuropsychopharmacology (AFPBN). RESULTS: Results show a potential efficacy of EEG-neurofeedback in the treatment of attentional-deficit/hyperactivity disorder (ADHD) in children, even if this is still debated. For other mental disorders, there is too limited research to warrant the use of EEG-neurofeedback in clinical practice. Regarding fMRI neurofeedback, the level of evidence remains too weak, for now, to justify clinical use. The literature review highlights various unclear points, such as indications (psychiatric disorders, pathophysiologic rationale), protocols (brain signals targeted, learning characteristics) and techniques (EEG, fMRI, signal processing). CONCLUSION: The field of neurofeedback involves psychiatrists, neurophysiologists and researchers in the field of brain computer interfaces. Future studies should determine the criteria for optimizing neurofeedback sessions. A better understanding of the learning processes underpinning neurofeedback could be a key element to develop the use of this technique in clinical practice.
OBJECTIVES: Neurofeedback is a technique that aims to teach a subject to regulate a brain parameter measured by a technical interface to modulate his/her related brain and cognitive activities. However, the use of neurofeedback as a therapeutic tool for psychiatric disorders remains controversial. The aim of this review is to summarize and to comment the level of evidence of electroencephalogram (EEG) neurofeedback and real-time functional magnetic resonance imaging (fMRI) neurofeedback for therapeutic application in psychiatry. METHOD: Literature on neurofeedback and mental disorders but also on brain computer interfaces (BCI) used in the field of neurocognitive science has been considered by the group of expert of the Neurofeedback evaluation & training (NExT) section of the French Association of biological psychiatry and neuropsychopharmacology (AFPBN). RESULTS: Results show a potential efficacy of EEG-neurofeedback in the treatment of attentional-deficit/hyperactivity disorder (ADHD) in children, even if this is still debated. For other mental disorders, there is too limited research to warrant the use of EEG-neurofeedback in clinical practice. Regarding fMRI neurofeedback, the level of evidence remains too weak, for now, to justify clinical use. The literature review highlights various unclear points, such as indications (psychiatric disorders, pathophysiologic rationale), protocols (brain signals targeted, learning characteristics) and techniques (EEG, fMRI, signal processing). CONCLUSION: The field of neurofeedback involves psychiatrists, neurophysiologists and researchers in the field of brain computer interfaces. Future studies should determine the criteria for optimizing neurofeedback sessions. A better understanding of the learning processes underpinning neurofeedback could be a key element to develop the use of this technique in clinical practice.
Authors: Lucas R Trambaiolli; Claudinei E Biazoli; André M Cravo; Tiago H Falk; João R Sato Journal: Neurophotonics Date: 2018-09-18 Impact factor: 3.593
Authors: David M A Mehler; Moses O Sokunbi; Isabelle Habes; Kali Barawi; Leena Subramanian; Maxence Range; John Evans; Kerenza Hood; Michael Lührs; Paul Keedwell; Rainer Goebel; David E J Linden Journal: Neuropsychopharmacology Date: 2018-06-23 Impact factor: 7.853